Boostrix tdap vaccine syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM5L9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,804
Award facts
- Contract value 100% obligated
- $3,804.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $3,804.30 to AmerisourceBergen Drug Corp for Boostrix TDAP vaccine in 0.5mL syringes, with a completion deadline of December 3, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, leverages this expansive IDC to supply a comprehensive range of pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities to support military and federal healthcare systems globally. The company's federal contract portfolio demonstrates consistent capability in delivering both brand-name and generic medications across multiple therapeutic domains, with previous delivery orders ranging from minimal to substantial values. This particular vaccine order supports the Defense Health Agency and broader military healthcare requirements, reflecting AmerisourceBergen's role as a primary pharmaceutical provider within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FM5L9?
SPE2DR26FM5L9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FM5L9 worth?
The government has obligated $3,804 on SPE2DR26FM5L9.
Is contract SPE2DR26FM5L9 an order under another contract?
Yes. SPE2DR26FM5L9 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM5L9 competed?
The extent of competition for SPE2DR26FM5L9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award